Negus et al., 1997 - Google Patents
Quantitative assessment of the leukocyte infiltrate in ovarian cancer and its relationship to the expression of CC chemokinesNegus et al., 1997
View PDF- Document ID
- 2857236182802864769
- Author
- Negus R
- Stamp G
- Hadley J
- Balkwill F
- Publication year
- Publication venue
- The American journal of pathology
External Links
Snippet
We have defined the host leukocyte infiltrate in epithelial ovarian tumors and related this to the expression of CC chemokines. Immunohistochemical analysis of 20 paraffin-embedded biopsies showed that the infiltrate was primarily composed of CD68+ macrophages and …
- 210000000265 Leukocytes 0 title abstract description 29
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
- G01N33/574—Immunoassay; Biospecific binding assay for cancer
- G01N33/57407—Specifically defined cancers
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Hybridisation probes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Negus et al. | Quantitative assessment of the leukocyte infiltrate in ovarian cancer and its relationship to the expression of CC chemokines | |
Fujii | New therapies and immunological findings in cutaneous T-cell lymphoma | |
Medina et al. | Mesenchymal stromal cells protect mantle cell lymphoma cells from spontaneous and drug-induced apoptosis through secretion of B-cell activating factor and activation of the canonical and non-canonical nuclear factor κB pathways | |
Shetty et al. | Measurement of apoptosis, proliferation and three cytokines in 46 patients with myelodysplastic syndromes | |
Chen et al. | Tumour inflammasome‐derived IL‐1β recruits neutrophils and improves local recurrence‐free survival in EBV‐induced nasopharyngeal carcinoma | |
Nishio et al. | Nurselike cells express BAFF and APRIL, which can promote survival of chronic lymphocytic leukemia cells via a paracrine pathway distinct from that of SDF-1α | |
Ohta et al. | The high expression of Fractalkine results in a better prognosis for colorectal cancer patients | |
Zeng et al. | Inhibition of CXCR4 with the novel RCP168 peptide overcomes stroma-mediated chemoresistance in chronic and acute leukemias | |
Merico et al. | Cytokines involved in the progression of multiple myeloma | |
Lee et al. | Chemokine receptor CXCR4 expression, function, and clinical implications in gastric cancer | |
Chen et al. | Dysregulated CXCR4 expression promotes lymphoma cell survival and independently predicts disease progression in germinal center B-cell-like diffuse large B-cell lymphoma | |
Venetz et al. | Perivascular expression of CXCL9 and CXCL12 in primary central nervous system lymphoma: T‐cell infiltration and positioning of malignant B cells | |
Plander et al. | Different proliferative and survival capacity of CLL-cells in a newly established in vitro model for pseudofollicles | |
Fecteau et al. | Structure and function of the hematopoietic cancer niche: focus on chronic lymphocytic leukemia | |
Silva et al. | Dual role of CCL3/CCR1 in oral squamous cell carcinoma: implications in tumor metastasis and local host defense | |
Ohshima et al. | Expression of chemokine receptor CXCR3 and its ligand, mig, in gastric and thyroid marginal zone lymphomas. Possible migration and autocrine mechanism | |
Yasutomi et al. | Erythromycin differentially inhibits lipopolysaccharide-or poly (I: C)-induced but not peptidoglycan-induced activation of human monocyte-derived dendritic cells | |
Lee et al. | Endogenous transmembrane protein UT2 inhibits pSTAT3 and suppresses hematological malignancy | |
Pribyl et al. | Aberrantly elevated suprabasin in the bone marrow as a candidate biomarker of advanced disease state in myelodysplastic syndromes | |
Nirschl et al. | Transcriptional profiling of tumor associated macrophages in human renal cell carcinoma reveals significant heterogeneity and opportunity for immunomodulation | |
Inaba et al. | mRNA expression of variant Fas molecules in acute leukemia cells | |
Semenzato et al. | Lung lymphocytes: origin, biological functions, and laboratory techniques for their study in immune-mediated pulmonary disorders | |
Pfister et al. | Chronic overexpression of membrane‐bound flt3 ligand by T lymphocytes in severe aplastic anaemia | |
Abulizi et al. | Hepatic alveolar echinococcosis infection induces a decrease in NK cell function through high expression of NKG2A in patients | |
Su et al. | Enhancing radiotherapy response via intratumoral injection of the TLR9 agonist CpG to stimulate CD8 T cells in an autochthonous mouse model of sarcoma |